Use of surface enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF MS) to study protein expression in a rat model of cocaine withdrawal

Journal of Neuroscience Methods

Volumn 158, Issue 1, 2006, Pages 1-12

  Geng, Tao ^a   Seitz, Patricia K ^a   Thomas, Mary L ^a   Xu, Bo ^a   Soman, Kizhake V ^a   Kurosky, Alexander ^a   Luxon, Bruce A ^a   Cunningham, Kathryn A ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Brain; Cocaine; Mass spectrometry; Proteomics; SELDI; SELDI TOF

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; COCAINE DEPENDENCE; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RAT; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; WITHDRAWAL SYNDROME;

ANIMALS; BEHAVIOR, ANIMAL; COCAINE; DISEASE MODELS, ANIMAL; MALE; PROTEIN ARRAY ANALYSIS; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUBCELLULAR FRACTIONS; SUBSTANCE WITHDRAWAL SYNDROME; VENTRAL TEGMENTAL AREA;

EID: 33749527527     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2006.04.025     Document Type: Article

References (67)

1. Aebersold R., and Mann M. Mass spectrometry-based proteomics. Nature 422 (2003) 198-207
2. Amado F.M.L., Santana-Marques M.G., Ferrer-Correia A.J., and Tomer KB. Analysis of peptide and protein samples containing surfactants by MALDI-MS. Anal Chem 69 (1997) 1102-1106
3. Beitner-Johnson D., Guitart X., and Nestler E.J. Neurofilament proteins and the mesolimbic dopamine system: common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area. J Neurosci 12 (1992) 2165-2176
4. Beitner-Johnson D., and Nestler E.J. Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions. J Neurochem 57 (1991) 344-347
5. Bienvenut W.V., Hoogland C., Greco A., Heller M., Gasteiger E., Appel R.D., et al. Hydrogen/deuterium exchange for higher specificity of protein identification by peptide mass fingerprinting. Rapid Commun Mass Spectrom 16 (2002) 616-626
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
7. Breaux G.A., Green-Church K.B., France A., and Limbach P.A. Surfactant-aided, matrix-assisted laser desorption/ionization mass spectrometry of hydrophobic and hydrophilic peptides. Anal Chem 72 (2000) 1169-1174
8. Carlezon J., and Nestler E. Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse?. Trends Neurosci 25 (2002) 610-615
9. Choudhary J., and Grant S.G.N. Proteomics in postgenomic neuroscience: the end of the beginning. Nat Neurosci 7 (2004) 440-445
10. Ciphergen Catalog; 2005a [http://www.ciphergen.com/doclib/docFiles/134.pdf].
11. Ciphergen Catalog; 2005b [http://www.ciphergen.com/MasterPage.aspx?URL=/products/pc/arrays_cons/arrays/general#h50].
12. Cordingley H.C., Roberts S.L., Tooke P., Armitage J.R., Lane P.W., Wu W., et al. Multifactorial screening design and analysis of SELDI-TOF ProteinChip array optimization experiments. Biotechniques 34 (2003) 364-373
13. De La Garza R., and Cunningham K.A. The effects of the 5-hydroxytryptamine(1A) agonist 8-hydroxy-2-(di-n-propylamino)tetralin on spontaneous activity, cocaine-induced hyperactivity and behavioral sensitization: a microanalysis of locomotor activity. J Pharmacol Exp Ther 292 (2000) 610-617
14. Filip M., Bubar M.J., and Cunningham K.A. Contribution of serotonin (5-Hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses. J Pharmacol Exp Ther 310 (2004) 1246-1254
15. Fountoulakis M. ELECTROPHORESIS|two-dimensional electrophoresis. In: Wilson I.D., Cooke M., and Poole C.F. (Eds). Encyclopedia of separation science (2000), Elsevier Ltd., Oxford 1356-1364
16. Fountoulakis M. Application of proteomics technologies in the investigation of the brain. Mass Spectrom Rev 23 (2004) 231-258
17. Fung E.T. Strategies in clinical proteomics: from discovery to assay. Preclinica 2 (2004) 253-258
18. Griffin T.J., and Aebersold R. Advances in proteome analysis by mass spectrometry. J Biol Chem 276 (2001) 45497-45500
19. Grus F.H., Podust V.N., Bruns K., Lackner K., Fu S., Dalmasso E.A., et al. SELDI-TOF-MS ProteinChip array profiling of tears from patients with dry eye. Invest Ophthalmol Vis Sci 46 (2005) 863-876
20. Heffner T.G., Hartman J.A., and Seiden L.S. A rapid method for the regional dissection of the rat brain. Pharmacol Biochem Behav 13 (1980) 453-456
21. Hope B.T. Cocaine and the AP-1 transcription factor complex. Ann NY Acad Sci 844 (1998) 1-6
22. Hope B.T., Crombag H.S., Jedynak J.P., and Wise R.A. Neuroadaptations of total levels of adenylate cyclase, protein kinase A, tyrosine hydroxylase, cdk5 and neurofilaments in the nucleus accumbens and ventral tegmental area do not correlate with expression of sensitized or tolerant locomotor responses to cocaine. J Neurochem 92 (2005) 536-545
23. Hutchens T.W., and Yip T.T. New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Commun Mass Spectrom 7 (1993) 576-580
24. Jeannot M.A., Zheng J., and Li L. Observation of gel-induced protein modifications in sodium dodecylsulfate [corrected] polyacrylamide gel electrophoresis and its implications for accurate molecular weight determination of gel-separated proteins by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. J Am Soc Mass Spectrom 10 (1999) 512-520
25. Jock CA, Paulauskis JD, Baker D, Olle E, Bleavins MR, Johnson KJ, et al. Influence of matrix application timing on spectral reproducibility and quality in SELDI-TOF-MS. Biotechniques 2004;37:30-2, 34.
26. Kalivas P.W., and Duffy P. Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J Neurosci 13 (1993) 266-275
27. Kalivas P.W., and McFarland K. Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berl) 168 (2003) 44-56
28. Kozell L.B., and Meshul C.K. Nerve terminal glutamate immunoreactivity in the rat nucleus accumbens and ventral tegmental area after a short withdrawal from cocaine. Synapse 51 (2004) 224-232
29. Krieg R.C., Fogt F., Braunschweig T., Herrmann P.C., Wollscheidt V., and Wellmann A. ProteinChip array analysis of microdissected colorectal carcinoma and associated tumor stroma shows specific protein bands in the 3.4 to 3.6 kDa range. Anticancer Res 24 (2004) 1791-1796
30. Lau C.E., Imam A., Ma F., and Falk J.L. Acute effects of cocaine on spontaneous and discriminative motor functions: relation to route of administration and pharmacokinetics. J Pharmacol Exp Ther 257 (1991) 444-456
31. Lewczuk P., Esselmann H., Groemer T.W., Bibl M., Maler J.M., Steinacker P., et al. Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease. Biol Psychiatry 55 (2004) 524-530
32. Lewczuk P., Esselmann H., Meyer M., Wollscheid V., Neumann M., Otto M., et al. The amyloid-beta (Abeta) peptide pattern in cerebrospinal fluid in Alzheimer's disease: evidence of a novel carboxyterminally elongated Abeta peptide. Rapid Commun Mass Spectrom 17 (2003) 1291-1296
33. Loftis J.M., and Janowsky A. Regulation of NMDA receptor subunits and nitric oxide synthase expression during cocaine withdrawal. J Neurochem 75 (2000) 2040-2050
34. Loo R.R., Dales N., and Andrews P.C. The effect of detergents on proteins analyzed by electrospray ionization. Methods Mol Biol 61 (1996) 141-160
35. Lu L., Dempsey J., Shaham Y., and Hope B.T. Differential long-term neuroadaptations of glutamate receptors in the basolateral and central amygdala after withdrawal from cocaine self-administration in rats. J Neurochem 94 (2005) 161-168
36. Lu L., Hope B.T., Dempsey J., Liu S.Y., Bossert J.M., and Shaham Y. Central amygdala ERK signaling pathway is critical to incubation of cocaine craving. Nat Neurosci 8 (2005) 212-219
37. Mehta A.I., Ross S., Lowenthal M.S., Fusaro V., Fishman D.A., Petricoin III E.F., et al. Biomarker amplification by serum carrier protein binding. Dis Markers 19 (2003) 1-10
38. Merchant M., and Weinberger S.R. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 21 (2000) 1164-1177
39. Molloy M.P., Herbert B.R., Walsh B.J., Tyler M.I., Traini M., Sanchez J.C., et al. Extraction of membrane proteins by differential solubilization for separation using two-dimensional gel electrophoresis. Electrophoresis 19 (1998) 837-844
40. Morris C.M., and Wilson K.E. High throughput approaches in neuroscience. Int J Dev Neurosci 22 (2004) 515-522
41. Morrison R.S., Kinoshita Y., Johnson M.D., Uo T., Ho J.T., McBee J.K., et al. Proteomic analysis in the neurosciences. Mol Cell Proteomics 1 (2002) 553-560
42. Nomura F., Tomonaga T., Sogawa K., Ohashi T., Nezu M., Sunaga M., et al. Identification of novel and downregulated biomarkers for alcoholism by surface enhanced laser desorption/ionization-mass spectrometry. Proteomics 4 (2004) 1187-1194
43. Olson V.G., Zabetian C.P., Bolanos C.A., Edwards S., Barrot M., Eisch A.J., et al. Regulation of drug reward by cAMP response element-binding protein: evidence for two functionally distinct subregions of the ventral tegmental area. J Neurosci 25 (2005) 5553-5562
44. Paradis V., Degos F., Dargere D., Pham N., Belghiti J., Degott C., et al. Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology 41 (2005) 40-47
45. Perrotti L.I., Bolanos C.A., Choi K.H., Russo S.J., Edwards S., Ulery P.G., et al. DeltaFosB accumulates in a GABAergic cell population in the posterior tail of the ventral tegmental area after psychostimulant treatment. Eur J Neurosci 21 (2005) 2817-2824
46. Petricoin E.F., and Liotta L.A. SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. Curr Opin Biotechnol 15 (2004) 24-30
47. Pierce R.C., and Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Rev 25 (1997) 192-216
48. Przegalinski E., Czepiel K., Nowak E., Dlaboga D., and Filip M. Withdrawal from chronic cocaine up-regulates 5-HT1B receptors in the rat brain. Neurosci Lett 351 (2003) 169-172
49. Righetti P.G., Castagna A., Antonioli P., and Boschetti E. Prefractionation techniques in proteome analysis: the mining tools of the third millennium. Electrophoresis 26 (2005) 297-319
50. Sauter E.R., Shan S., Hewett J.E., Speckman P., and Du Bois G.C. Proteomic analysis of nipple aspirate fluid using SELDI-TOF-MS. Int J Cancer 114 (2005) 791-796
51. Scopes R.K. Strategies of protein purification and characterization. In: Coligan J.E., Dunn B.M., Speicher D.W., and Wingfield P.T. (Eds). Current protocols in protein science (2005), John Wiley & Sons
52. Sedmak J.J., and Grossberg S.E. A rapid, sensitive, and versatile assay for protein using Coomassie brilliant blue G250. Anal Biochem 79 (1977) 544-552
53. Self D.W., Choi K.H., Simmons D., Walker J.R., and Smagula C.S. Extinction training regulates neuroadaptive responses to withdrawal from chronic cocaine self-administration. Learn Mem 11 (2004) 648-657
54. Semmes O.J., et al. Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. Clin Chem 51 (2005) 102-112
55. Sutton M.A., Schmidt E.F., Choi K.H., Schad C.A., Whisler K., Simmons D., et al. Extinction-induced upregulation in AMPA receptors reduces cocaine-seeking behaviour. Nature 421 (2003) 70-75
56. Tirumalai R.S., Chan K.C., Prieto D.A., Issaq H.J., Conrads T.P., and Veenstra T.D. Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics 2 (2003) 1096-1103
57. Tonge R., Shaw J., Middleton B., Rowlinson R., Rayner S., Young J., et al. Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 1 (2001) 377-396
58. Vanderschuren L.J., and Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) 151 (2000) 99-120
59. Vorderwulbecke S., Cleverley S., Weinberger S.R., and Wiesner A. Protein quantification by the SELDI-TOF-MS-based ProteinChip[reg] System. Nat Methods 2 (2005) 393-395
60. Vorm O., Chiat B., and Roepstorff P. Mass spectrometry of protein samples containing detergents. Am Soc Mass Spectrom 41 (1994) 621a-621b
61. White F.J., and Kalivas P.W. Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend 51 (1998) 141-153
62. Williams K., Wu T., Colangelo C., and Nairn A.C. Recent advances in neuroproteomics and potential application to studies of drug addiction. Neuropharmacology 47 Suppl. 1 (2004) 148-166
63. Wittke S., Kaiser T., and Mischak H. Differential polypeptide display: the search for the elusive target. J Chromatogr B Analyt Technol Biomed Life Sci 803 (2004) 17-26
64. Woong-Shick A., Sung-Pil P., Su-Mi B., Joon-Mo L., Sung-Eun N., Gye-Hyun N., et al. Identification of hemoglobin-alpha and -beta subunits as potential serum biomarkers for the diagnosis and prognosis of ovarian cancer. Cancer Sci 96 (2005) 197-201
65. Yuan M., and Carmichael W.W. Detection and analysis of the cyanobacterial peptide hepatotoxins microcystin and nodularin using SELDI-TOF mass spectrometry. Toxicon 44 (2004) 561-570
66. Zhou W., Cunningham K.A., and Thomas M.L. Estrogen regulation of gene expression in the brain: a possible mechanism altering the response to psychostimulants in female rats. Mol Brain Res 100 (2002) 75-83
67. Zhu K., Miller F.R., Barder T.J., and Lubman D.M. Identification of low molecular weight proteins isolated by 2-D liquid separations. J Mass Spectrom 39 (2004) 770-780